References
- International Diabetes FederationIDF Diabetes Atlas6th edBrussels, BelgiumInternational Diabetes Federation2013 Available from: http://www.idf.org/diabetesatlasAccessed November 18, 2014
- JuurinenLTiikkainenMHäkkinenAMHakkarainenAYki-JärvinenHEffects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetesAm J Physiol Endocrinol Metab20072923E829E83517090752
- LevitSToledanoYWainsteinJImproved glycaemic control with reduced hypoglycaemic episodes and without weight gain using long-term modern premixed insulins in type 2 diabetesInt J Clin Pract201165216517121166963
- Yki-JärvinenHCombination therapies with insulin in type 2 diabetesDiabetes Care200124475876711315844
- LiWMinRDongYLiZSunQLiYUsing continuous glucose monitoring to measure glucose variation of patients with type 2 diabetes: switching from premixed human insulin 70/30 to insulin lispro mix 75/25 or lispro mix 50/50 for 8 weeksJournal of Diabetes Research and Clinical Metabolism2013215
- RoachPTrautmannMAroraVSunBAndersonJHJrImproved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study groupClin Ther199921352353410321421
- LiYLiQLiCJComparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25 or twice daily human insulin mix 30/70Chin Med J (Engl)2009122212540254619951567
- World Health OrganizationDefinition and diagnosis of diabetes mellitus and intermediate hyperglycemia2006 Available from: http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdfAccessed November 18, 2014
- RaskinPAllenEHollanderPINITIATE study groupInitiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogsDiabetes Care200528226026515677776
- YangWJiQZhuDBiphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugsDiabetes Care200831585285618268073
- LingvayILegendreJLKaloyanovaPFZhangSAdams-HuetBRaskinPInsulin-based versus triple oral therapy newly diagnosed type 2 diabetes: which is better?Diabetes Care200932101789179519592630
- IlagLLKerrLMaloneJKTanMHPrandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparisonClin Ther2007296 Pt 112541270
- RollaARRakelREPractical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analoguesClin Ther20052781113112516199240
- MonnierLLapinskiHColetteCContributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)Diabetes Care200326388188512610053
- JiaWPPangCChenLEpidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communitiesDiabetologia200750228629217180353
- LiLMRaoKQKongLZA description on the Chinese national nutrition and health survey in 2002Zhonghua Liu Xing Bing Xue Za Zhi2005267478484 Chinese16334996
- AnYLGaoYZhuQFeatures of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indicesZhonghua Yi Xue Za Zhi2009891611171121 Chinese19595144
- PolonskyKSGivenBDVan CauterETwenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjectsJ Clin Invest19888124424483276730
- HermanWHIlagLLJohnsonSLA clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetesDiabetes Care20052871568157315983302
- IbrahimIABeichJSidorovJGabbayRYuLMeasuring outcomes of type 2 diabetes disease management program in an HMO settingSouth Med J2002951788711827249